| Long name: |
FITC Conjugated, H1N1 Hemagglutinin 1 Polyclonal Antibody |
| Category: |
Conjugated Primary Antibodies |
| Conjugation: |
Anti-FITC Antibody |
| Host Organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Antigen: |
H1N1 Hemagglutinin 1 |
| Specificity: |
This is a highly specific antibody against H1N1 Hemagglutinin 1 |
| Modification: |
Unmodified |
| Modification site: |
None |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Immunogen_range: |
180-230/566 |
| Subcellular location: |
Membrane bound |
| Source: |
KLH conjugated synthetic peptide derived from Influenza A Virus Hemagglutinin (strain swl A/California/04/2009 H1N1) |
| Swiss Prot: |
C3W5S1 |
| Tested applications: |
IF(IHC-P) |
| Recommended dilutions: |
IF(IHC-P)(1:50-200) |
| Crossreactivity: |
Virus |
| Crossreactive species details: |
Influenza A virus H1N1 (strain swl A/California/04/2009 H1N1) |
| Antigen background: |
Binds to sialic acid-containing receptors on the cell surface, Class I viral fusion protein, HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues, Influenza A Virus (strain swl A/California/04/2009 H1N1), Influenza A can exist in a variety of animals, Low pH in endosomes induces an irreversible conformational change in HA2, Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, Plays a major role in the determination of host range restriction and virulence, Responsible for penetration of the virus into the cell cytoplasm by mediating the fusion of the membrane of the endocytosed virus particle with the endosomal membrane, Several trimers are required to form a competent fusion pore, These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes, This attachment induces virion internalization of about two third of the virus particles through clathrin-dependent endocytosis and about one third through a clathrin- and caveolin-independent pathway, bringing about the attachment of the virus particle to the cell, however it is in birds that all subtypes can be found, releasing the fusion hydrophobic peptide, resulting in devastating pandemics, Influenza A virus is a major public health threat |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission: |
494nm/518nm |
| Synonyms: |
Hemagglutinin, Influenza A Virus (strain swl A/California/04/2009 H1N1), HA |
| Properties: |
Bioss Primary Conjugated Antibodies FITC is highly sensitive to pH extremes, FITC has a green emission that's usually collected at 530 nanometers, FITC has a high quantum yield (efficiency of energy transfer from absorption to emission fluorescence) and approximately half of the absorbed photons are emitted as fluorescent light, For fluorescent microscopy applications, This Bioss Primary Conjugated Antibodies Fluorescein isothiocyanate (FITC) antibody is currently after some BD antibodies the most commonly used fluorescent dye for FACS, When excited at 488 nanometers, its photo bleaching effects are not observed due to a very brief interaction at the laser intercept, the 1 FITC is seldom used as it photo bleaches rather quickly though in flow cytometry applications, the FL1 detector of a FACSCalibur or FACScan, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
H1N1 Hemagglutinin 1 Conjugated |
| Short name: |
FITC Conjugated, H1N1 Hemagglutinin 1 Antibody |
| Technique: |
Fluorescein, antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label: |
FITC |
| Alternative name: |
fluorecein coupled, H1N1 Hemagglutinin 1 (Antibody to) |
| Alternative technique: |
antibodies |